medigraphic.com
ISSN 1561-2937 (Print)

2021, Number 3

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2021; 27 (3)

Cardiovascular adverse events in women with multivessel coronary arterial disease

Borges MY, Peix GA, Rodríguez NL, Castelo VX, Heres AF, Jerez CAM

Language: Spanish
References: 31
Page: 1-9
PDF size: 408.61 Kb.


ABSTRACT

Introduction: Cardiovascular disease is the leading cause of death in female population of the world, being multivessel coronary artery disease the principal responsible for these deaths.
Objective: To identify the possible relationship of clinical, diagnostic and therapeutic variables with cardiovascular adverse events in women with multivessel coronary arterial disease, at Cardiovascular Institute from January 2016 to December 2018.
Method: Observational, descriptive and prospective survey involving 107 female patients admitted in this period in Cardiovascular Institute, with diagnosis of multivessel coronary arterial disease.
Results: The mean age was 66, 5 years. Hypertension and diabetes were the most frequent risk factors. Early menopause was reported in 43, 9% of the sample and gestational diabetes was commonly stated. Multivessel coronary arterial disease without lead mean affection was found in 71% of patients. Angioplasty was performance in 61, 7% of these women. 51,4% of all adverse events occurred during the first year of follow up. Cardiovascular adverse events were toughly associated to obstetric variables.
Conclusions: Cardiovascular adverse events were more associated with obstetric variables than others (clinical, diagnostic and therapeutic variables) in women with multivessel coronary arterial disease.


REFERENCES

  1. Tailor DT, Kicska GA, Jacobs EJ, Pampaloni MH, Litmanovich DE, Reddy GP. Imaging of heart disease in women. Radiology[Internet]. 2017Jan [cited 2017Apr16];282(1):34-53. Available from: https://pubs.rsna.org/doi/pdf/10.1148/radiol.2016151643.

  2. Braunwald E. Tratado de cardiología: Texto de medicina cardiovascular. 10ma ed. Vol. 2. España: Elsevier Saunders, 2016. 1744-49p

  3. Ten Haaf ME, Bax M, Ten Berg JM, Brower J, Van' T Hof AW, Van der Schaaf RJ, et al. Sex differences in characteristics and outcome in acute coronary síndrome patients in the Netherlands. NethheartJ [Internet]. 2019Apr [citado 12Jul2019]; 27:263-71. Disponible en: https://link.springer.com/article/10.1007%2Fs12471-019-1271-0

  4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bo M, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens [Internet]. 2013Oct [cited 2017Apr17];31(10):1925-38. Available from:https://journals.lww.com/jhypertension/fulltext/2013/10000/2013_Practice_guidelines_for_the_management_of.2.aspx#pdf-link.

  5. Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud 2018 [Internet]. La Habana: MINSAP; 2018 [citado 6 may 2019]. 91-5 p. Disponible en: http://files.sld.cu/dne/files/2018/04/Anuario-Electronico-Espa%C3%B1ol-2017-ed-2018.pdf

  6. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden CH, Budaj A, et al. Guía de prácticas clínicas de la ESC sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Rev Esp Cardiol [Internet]. 2014 Ene [citado 23 Abr 2019];67(2):80-86. Disponible en: https://www.revespcardiol.org/es-pdf-S030089321400030X

  7. Wu P, Mamas AM. Gulati M. Pregnancy as a predictor of maternal cardiovascular disease: The era of CardioObstetrics. Journal of Women's Health . 2019; 28.8 : 1037-1050.

  8. Bassily E, Bell C, Verma S, Patel N, Patel A. Significance of obstetrical History with Future Cardiovascular Disease Risk. The American Journal of Medicine 2018. DOI:https://doi.org/10.1016/j.amjmed.2018.11.029.

  9. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd- Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: A guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404–23.

  10. Novack K, Vrdoljak D, Jelaska I, Borovac JA. Sex-specific differences in risk factors for in-hospital mortality and complications in patients with acute coronary syndromes. Wien Klin Wochenschr[Internet]. 2017Apr [cited 2019Apr17];129(7-8):232-42. Available from: https://link.springer.com/content/pdf/10.1007%2Fs00508-016-1105-7.pdf

  11. Redondo A, González R, Abu Assi E, Raposeiras S, Saidhodjayeva O, López A, et al. Pronóstico de largo plazo de pacientes con infarto agudo de miocardio sin elevación del ST y arterias coronarias sin estenosis significativas. [carta al editor]. Rev Esp Cardiol [Internet]. 2015 Sep [citado 17Apr2019];68(9):820-22. Disponible68 en: https://www.revespcardiol.org/index.php?p=revista&tipo=pdf-simple&pii=S0300893215002079

  12. Yanfei L Tiejun T, Rui G, Yue L, et al. The association of depression following percutanous coronary intervention with adverse cardiovascular events. Medicine [Internet, Yinke Z, Jinfan T,]. 2019Jan [cited 2019Jul20]; 98(2): [About 1-5 p.]. Available from: https://insights.ovid.com/crossref?an=00005792-201901110-00024.

  13. Barreda AM, López L, Rodríguez L, Gónzalez AB, Antuña T, Borges Y. Caracterización de las mujeres con intervencionismo coronario percutáneo ICCCV 2011-2015. Rev Cuban Cardiol [Internet]. 2018 Oct [citado 8 Jul 2019];24(2):pp. Disponible en:http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/776/pdf_129

  14. Schwarzer KL, Schaan de Quadros A, Regis M, Mascia CA, Moura M. Anger and Coronary Artery Disease in Woman submitted to Coronary Angiography: A 48-Month Follow-Up. Arq Bras Cardiol[Internet]. 2018 Apr [cited 2019 Jul 20]; 111(3): [About 410-16 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173346/pdf/abc-111-03-0410.pdf.

  15. Jiménez J, Díaz O, Barrrabés JA, García B, Bodí V, López R, et al. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos. Rev Esp Cardiol [Internet]. 2013 Mar [citado 6 May 2017];66 (3):198-204. Disponible en: http://www.revespcardiol.org/es/vol-66-num-03/sumario/13015518/

  16. Vidal R, Otero F, Gómez JL, Santos JA, De Frutos C, Gónzalez JR. Cardiopatía isquémica en la mujer. Datos del estudio CIBAR. Rev Esp Cardiol [Internet]. 2012 Nov [citado 6 May 2017];65 (1):1056-8. Disponible en: http://www.revespcardiol.org/es/cardiopatia-isquemica-mujer-datos-del/articulo/90156804/

  17. García L, Cáceres C, Gómez N, Paniagua M, Lovera O, Centurión OM, et al. Factores de riesgos y cardiopatías prevalentes en mujeres internadas en la división de medicina cardiovascular del Hospital de Clínicas. Cienc Salud [Internet]. 2017 Mar [citado 23 Abr 2019]; 15(2):45-55. Disponible en: Doi: 10.18004/Mem.iics/1812-9528/2017.015(02)45-055

  18. Ching Ching T, Ming Hsiung H, Hung Yu Y, Chan P, Chii J, et al. Predictors of coronary artery disease in middle – aged Taiwanese woman at premenopause, postmenopause and after undergoing hysterectomy. jCN [Internet]. 2016Feb [cited 2019Jul30];25: [About 2438-49 p.]. Available from: https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocn.13258

  19. Adik Pathak L, Shirodkar S, Ruparelia R, Rajebahadur J. Coronary artery disease in women. Indian Heart Journal [Internet]. 2017Jun [cited 2019Jul20];69:[About 532-38 p.].Availablefrom: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560902/pdf/main.pdf

  20. Babu E, Balachander J. Angiography prevalence and pattern of coronary artery disease in women. Indian heart Journal [Internet]. 2014 Jun [cited 2019 Jul 20];66:[About 422-26 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150037/pdf/main.pdf

  21. Bueno H, Pocock S, Medina J, Danchin N, Annemans L, Licour M, et al. Relación entre situaciones clínicas que llevan al tratamiento exclusivamente farmacológico del SCASEST y su pronóstico. Rev Esp Cardiol [Internet]. 2017 Jun [citado 23 Abr 2019]; 70(10):817-824. Disponible en: https://www.revespcardiol.org/es-pdf-S0300893216307436.

  22. Siew Mooi CH, Yook Chin CH, Lentjes M, Luben R, Wareham N, Kay Tee K, et al. FEVI and Cardiovascular mortality and morbility over a n 18 years follow-up Population-Based Prospective EPIC-NORFOLK Study. BMC Public Health[Internet]. [Internet]. 2019 Jul [cited 2019 Jul 10];19: [About 501 p.]. Available from: https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-019-6818-x.

  23. Perdoncin E, Duvernoy C. Treatment of Coronary Artery disease in Women. Journal Houstonmethodist [Internet]. 2017 [cited 2019 Jul 20];13(4):[About 201-8 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935279/pdf/i1947-6094-13-4-201.pdf.

  24. Maron DJ, Hochman JS, O´Brien SM, Reynolds AR, Boden WE, Piedra GW, et al. Estudio internacional de la eficacia comparativa de la salud con un enfoque médico invasivo(ISQUEMIA): Justuficación y diseño. Am Heart J [Internet]. 2018 Jul [citado 23 Abr 2019];201:124-125. Disponible en: doi:10.1016/j.ahj.2018.04011

  25. Jinling M, Xiujie W, Meng G, Yadong G. Effect of smoking status on coronary artery disease amomg Chinese post-menopausal women. Inter Emerg Med [Internet]. 2016Oct [cited 2019Jul20];11:[About 529-35 p.]. Available from: https://link.springer.com/content/pdf/10.1007%2Fs11739-015-1334-1.pdf

  26. Sánchez JJ, Ruíz M, Paredes N, Oneto MJ, Luque A, Romo E, et al Supervivencia libre de eventos cardiovasculares mayores en el seguimiento a largo plazo de una cohorte de pacientes con cardiopatía isquémica estable. Rev Esp Cardiol [Internet]. 2018 Ago [citado 20 Jul 2019];71 Supl 1:S945. Disponible en: https://www.revespcardiol.org/es-congresos-sec-2018-el-congreso-76-sesion-cardiopatia-isquemica-cronica-4406-supervivencia-largo-plazo-una-poblacion-52012-pdf

  27. Risse HK, Sulo G, Tell GS, Igland J, Nygard O, Vollset SE, et al. Incident coronary heart disease after preeclampsia: Role of reduced fetal growth, preterm delivery, and parity. J Am Heart Assoc 2017;6: e004158

  28. Saldarriaga CI, Franco G, Garzón AM, García I, Mejía N, Restrepo A. Factores de riesgo para la enfermedad coronaria temprana en mujeres. Biomédica 2010; 30:559-66.

  29. Madonna R, Balistreri CR, De Rosa S, Muscoli S, Selvaggio S, selvaggio G, et al. Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease. J. Clin. Med [Internet]. 2019 Jan [cited 2019 Jul 20];8(98): [About 1-18 p.]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351940/pdf/jcm-08-00098.pdf

  30. Morales R, Valadròn I, Maristany J, Alamar M, Massò Van A, Morcuende A, et al. Seguimiento a largo plazo tras revascularización coronaria percutánea: Factores predictores de muerte cardiovascular, infarto agudo de miocardio y accidente cerebrovascular. Rev Esp Cardiol [Internet]. 2018Jul [citado 20Jul2019]; 71 Supl 1:S1132. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671445/pdf/ethndis-25-499.pdf.

  31. Viana MC, Silva A, Arroyo R, Estrella A, Uribe G, Saboya S, et al. Las mujeres presentan una mayor mortalidad tras un Síndrome coronario agudo con elevación del ST, independientemente de la edad, gravedad clínica y fragilidad biológica. Rev Esp Cardiol [Internet]. 2018"[mes con 3 letras, inicial en mayúscula]" [citado 10Jul2019]; 71 (Supl 1):S32. Disponible en: https://www.revespcardiol.org/es-congresos-sec-2018-el-congreso-76-sesion-diferencias-por-sexo-cardiopatias-4318-las-mujeres-presentan-una-mayor-51084-pdf.




2020     |     www.medigraphic.com